Xconomy’s Digital Events →
OSI Pharmaceuticals is a subsidiary of Astellas Pharma making cancer drugs.
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
Sponsored · Video
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
From Our Editors · Special Report
The AI, Big Data, and R&D Boom
© 2007-2022, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.